
|

| |
Track the *RXGNE Index |
 |
|
 | Genetic Analysis Stocks (*RXGNE) |
| |
Genetic Analysis Ideas |
|
|
|
Genetic Analysis Performance |
|
|
|
Genetic Analysis Community |
|
| |
|
Index Description: Firms involved in the burgeoning field of genetic analysis and testing
|
|
|
|
|
Today:
1-month:
All-time:
|
+0.1%
+4.6%
+23.1%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
+0.2%
+5.4%
+3.2%
|
Avg. Market Cap:
Avg. P/E Ratio:
Avg. Div Yield:
|
$2.0B
56.2
0.0%
|
|
|
|
|
Share this Index on Facebook
Share this Index on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |

|
| |
|
| |

|
| |
Supreme Court Denies Human Gene Patents MYGN QGEN GENE
Linked by Energy and Capital ( track newsfeed | ignore newsfeed ) - June 17, 01:40PM from (www.energyandcapital.com) The Supreme Court rules against human gene patents in a severe blow to Myriad Genetics (NASDAQ: MYGN).
Flag
Post a comment
DaVita Labs and Myriad RBM Announce Biomarker Research Collaboration MYGN DVA
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 17, 07:13AM from (globenewswire.com) SALT LAKE CITY, June 17, 2013 (GLOBE NEWSWIRE) -- DaVita Labs, a unit of DaVita HealthCare Partners Inc. (NYSE:DVA) and Myriad
Flag
Post a comment
Mid-Afternoon Market Update: Walter Energy Plummets as Oil Posts a Strong Rally SFD WLT MYGN HIMX GRPN RH
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 14, 03:42PM from (www.benzinga.com) Toward the end of trading Friday, the Dow traded down 0.51 percent to 15,099.70 while the NASDAQ declined 0.41 percent to
Flag
Post a comment
Mid-Day Market Update: Stocks Move Lower, Groupon Rises on Analyst Upgrade SFD PRGS MYGN BEE HIMX GRPN RH
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 14, 12:54PM from (www.benzinga.com) Midway through trading Friday, the Dow traded down 0.50 percent to 15,100.70 while the NASDAQ declined 0.41 percent to 3,431.08.
Flag
Post a comment
'Happy Birthday' the Subject of Newest Copyright Litigation AAPL MYGN TWX
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 14, 11:37AM from (www.benzinga.com) First there was the Apple (NASDAQ: AAPL) versus Samsung battle that has continued to crown winners on both sides.
Flag
Post a comment
Myriad Ruling Causes 15 Percent Swing Thursday – Here's Why MYGN DGX
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 14, 08:03AM from (www.benzinga.com) Apparently, Wall Street investors need to dust off their old biology textbooks and do some reading because Thursday’s Supreme
Flag
Post a comment
Myriad Gene Patent Ruling Triggers Race for Cancer Tests MYGN DGX
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - June 14, 12:29AM from (www.bloomberg.com) Companies and a university are moving to offer cheaper and broader genetic testing for breast cancer risk to a growing group
Flag
Post a comment
After DNA Patent Ruling, Availability of Genetic Tests Could Broaden BRLI MYGN DGX
Linked by NYTimes ( track newsfeed | ignore newsfeed ) - June 13, 09:29PM from (www.nytimes.com) The Supreme Court’s decision in effect ends a nearly two-decade monopoly by Myriad Genetics on genes that correlate with
Flag
Post a comment
Myriad Genetics Up 8% on Supreme Court Ruling MYGN
Linked by YCHARTS ( track newsfeed | ignore newsfeed ) - June 13, 01:43PM from (ycharts.com) Myriad Genetics (MYGN) stock jumped after a Supreme Court ruling that invalidated two of the company’s patents, but left
Flag
Post a comment
Supreme Court Upholds Myriad's cDNA Patent Claims MYGN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 13, 12:43PM from (globenewswire.com) SALT LAKE CITY, June 13, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today said the Supreme Court of the
Flag
Post a comment
Supreme Court Justices Unanimous on Denying Patents for Human Genes MYGN
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - June 13, 11:40AM from (247wallst.com) The U.S. Supreme Court issued a unanimous 9-0 ruling today denying patent protection from human genes isolated from the body.
Flag
Post a comment
Short Interest Falls in Vertex, Rises in Biogen Idec BMY PFE MRK AMGN CELG REGN BIIB VRTX VVUS GILD ALXN PCYC ONXX ARNA DNDN ILMN NVS
Linked by Benzinga.com ( track newsfeed | ignore newsfeed ) - June 12, 01:29PM from (www.benzinga.com) Among biotech and emerging pharmaceutical companies, Biogen Idec (NASDAQ: BIIB), saw the most significant rise in short interest
Flag
Post a comment
Myriad Genetics to Present at the Goldman Sachs Global Healthcare Conference MYGN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 03, 07:13AM from (globenewswire.com) SALT LAKE CITY, June 3, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum,
Flag
Post a comment
AstraZeneca Advances PARP Inhibitor Into Phase 3 Trial With BRACAnalysis(R) MYGN
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - June 01, 08:13AM from (globenewswire.com) SALT LAKE CITY, June 1, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that AstraZeneca will
Flag
Post a comment
|
|
|